Advertisement Faubel Showcases Specialist Labelling for the Pharmaceutical and Chemical Industries at Interpack - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about Faubel

Faubel Showcases Specialist Labelling for the Pharmaceutical and Chemical Industries at Interpack

Faubel has more surprises in store for attendees than in previous years. In the last few months, Faubel has not only relaunched its corporate design, but also expanded its product portfolio.

"The pharmaceutical and chemical industries require our products to meet high standards of quality. These requirements make us more innovative, which results in highly specialised and customized labeling solutions," explains Reinhard Kuge, CEO at Faubel.

Index label – instant access

Faubel offers a multi-page Compact label with colored index as a unique alternative to an ordinary table of contents. The thumb index makes it easier for users to instantly access important information inside the booklet.

faubel
Faubel-Index Label: An index gives a user-friendly structure to any booklet label

Synthetic label – highly resistant

Made of synthetic paper, the Faubel-Compact® label benefits from the positive properties of plastic material. It is tear-resistant, waterproof and resistant to grease and chemicals, making it suitable for a multitude of applications.

CRSF label – safety first

The CRSF label from Faubel offers an effective way of making standard blister packs childproof during downstream processing, yet still guarantees packaging that is senior-friendly. The safety element is suitable for machine processing, and is certified to DIN EN 134375 and US 16 CFR § 1700.20 (F1) standards.

Blinding solutions – no tampering

Faubel blinding solutions are products that are used for single or double-blind clinical trials. Vials, bottles, pots, tubes and blister packs can be fully covered and protected against tampering.

blinding-solutions

Faubel-Blinding Solutions: The success of a clinical trial is improved by first-class blinding for the study medication.